199 related articles for article (PubMed ID: 34330233)
1. Prognostic significance of occult lymph node metastases in breast cancer: a meta-analysis.
Wang G; Zhang S; Wang M; Liu L; Liu Y; Tang L; Bai H; Zhao H
BMC Cancer; 2021 Jul; 21(1):875. PubMed ID: 34330233
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases.
de Boer M; van Dijck JA; Bult P; Borm GF; Tjan-Heijnen VC
J Natl Cancer Inst; 2010 Mar; 102(6):410-25. PubMed ID: 20190185
[TBL] [Abstract][Full Text] [Related]
3. Effect of occult metastases on survival in node-negative breast cancer.
Weaver DL; Ashikaga T; Krag DN; Skelly JM; Anderson SJ; Harlow SP; Julian TB; Mamounas EP; Wolmark N
N Engl J Med; 2011 Feb; 364(5):412-21. PubMed ID: 21247310
[TBL] [Abstract][Full Text] [Related]
4. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
[TBL] [Abstract][Full Text] [Related]
7. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
[TBL] [Abstract][Full Text] [Related]
8. Axillary lymph node micrometastases decrease triple-negative early breast cancer survival.
Houvenaeghel G; Sabatier R; Reyal F; Classe JM; Giard S; Charitansky H; Rouzier R; Faure C; Garbay JR; Daraï E; Hudry D; Gimbergues P; Villet R; Lambaudie E
Br J Cancer; 2016 Oct; 115(9):1024-1031. PubMed ID: 27685443
[TBL] [Abstract][Full Text] [Related]
9. The inconsistency of molecular subtypes between primary foci and metastatic axillary lymph nodes in Luminal A breast cancer patients among Chinese women, an indication for chemotherapy?
Sun Y; Liu X; Cui S; Li L; Tian P; Liu S; Li Y; Yin M; Zhang C; Mao Q; Wang J
Tumour Biol; 2016 Jul; 37(7):9555-63. PubMed ID: 26790445
[TBL] [Abstract][Full Text] [Related]
10. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of occult lymph node metastases in node-negative breast cancer.
Clare SE; Sener SF; Wilkens W; Goldschmidt R; Merkel D; Winchester DJ
Ann Surg Oncol; 1997 Sep; 4(6):447-51. PubMed ID: 9309332
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of occult micrometastases in axillary lymph nodes in "node-negative" breast cancer patients.
Umekita Y; Ohi Y; Sagara Y; Yoshida H
Jpn J Cancer Res; 2002 Jun; 93(6):695-8. PubMed ID: 12079518
[TBL] [Abstract][Full Text] [Related]
14. Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancer.
Wu Y; Mittendorf EA; Kelten C; Tucker SL; Wei W; Middleton LP; Broglio K; Buchholz TA; Hunt KK; Sahin AA
Cancer; 2012 Mar; 118(6):1507-14. PubMed ID: 22009292
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
16. Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases.
Nogami T; Shien T; Tanaka T; Nishiyama K; Mizoo T; Iwamto T; Ikeda H; Taira N; Doihara H; Miyoshi S
Breast Cancer; 2014 Jan; 21(1):58-65. PubMed ID: 22407396
[TBL] [Abstract][Full Text] [Related]
17. [Axillary Lymph Nodes Metastases from Occult Breast Cancer Recurrence at Ten Years after Resection--Case Report].
Nagashima S; Sakurai K; Suzuki S; Sakagami M; Adachi K; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1776-8. PubMed ID: 26805169
[TBL] [Abstract][Full Text] [Related]
18. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up.
Tan LK; Giri D; Hummer AJ; Panageas KS; Brogi E; Norton L; Hudis C; Borgen PI; Cody HS
J Clin Oncol; 2008 Apr; 26(11):1803-9. PubMed ID: 18332473
[TBL] [Abstract][Full Text] [Related]
19. Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis.
Sanghani M; Balk EM; Cady B
Cancer; 2009 Apr; 115(8):1613-20. PubMed ID: 19199349
[TBL] [Abstract][Full Text] [Related]
20. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
